New Jersey stands to get a total $641 million from a national settlement with opioid manufacturer Johnson & Johnson and pharmaceutical distributors McKesson, Cardinal Health, and AmerisourceBergen.
Camden County’s cut will amount to $32 million over the next 18 years.
Early plans for spending the money include the launch of a pilot program that involves dispensing buprenorphine — one kind of opioid medication-assisted treatment — from a mobile outreach van.
Medication-assisted treatments like methadone, buprenorphine, and naltrexone are effective in helping people manage a substance use disorder. However, they typically require people to travel, sometimes long distances, to a treatment center.
The pilot program aims to bring treatment options closer, officials said. It will launch sometime this summer.
Dr. Matthew Salzman is an addiction medicine specialist at Cooper University Health Care. He said the mobile van will be part of the medical school’s street medicine initiative.
“These are students and staff who go out into the community of people who are experiencing homelessness to engage them, provide them with services, a lot of whom are really reluctant to seek health care,” Salzman said. “This is an opportunity to not just conceptually, but physically meet them where they are.”